A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer
Abstract Background There is an obvious correlation between ulcerative colitis and colorectal cancer, and the risk of colorectal cancer in patients with ulcerative colitis is increasing. Therefore, the combination therapy of anti-inflammatory and anti-tumor drugs may show promising to inhibit colon...
Main Authors: | Lin Chen, Yan Lin, Zijun Zhang, Ruisheng Yang, Xiaosheng Bai, Zhongbing Liu, Zhongling Luo, Meiling Zhou, Zhirong Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-021-01064-3 |
Similar Items
-
A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model
by: Yang Y, et al.
Published: (2018-12-01) -
Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
by: Yan Yan, et al.
Published: (2019-12-01) -
N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis
by: Jaejeong Kim, et al.
Published: (2023-11-01) -
Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis
by: Wooseong Kim, et al.
Published: (2019-11-01) -
Secondary Bile Acids and Short Chain Fatty Acids in the Colon: A Focus on Colonic Microbiome, Cell Proliferation, Inflammation, and Cancer
by: Huawei Zeng, et al.
Published: (2019-03-01)